Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-29 Sale |
2025-01-30 12:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
825 | $29.52 | $24,357 | 83,664 (Direct) |
View |
2025-01-22 Sale |
2025-01-23 3:31 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
3,948 | $30.43 | $120,120 | 84,489 (Direct) |
View |
2025-01-17 Sale |
2025-01-21 4:09 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
2,145 | $29.96 | $64,260 | 88,437 (Direct) |
View |
2025-01-13 Sale |
2025-01-14 4:22 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
2,632 | $28.7 | $75,544 | 54,156 (Direct) |
View |
2024-03-13 Sale |
2024-03-14 4:17 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
11,220 | $57.56 | $645,838 | 56,287 (Direct) |
View |
2024-01-29 Sale |
2024-01-31 4:31 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
835 | $64.14 | $53,555 | 67,507 (Direct) |
View |
2024-01-22 Sale |
2024-01-23 6:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
2,593 | $65 | $168,535 | 68,342 (Direct) |
View |
2024-01-16 Sale |
2024-01-17 4:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
1,857 | $66.81 | $124,064 | 99,302 (Direct) |
View |
2023-09-18 Sale |
2023-09-19 5:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
20,350 | $44.27 | $900,813 | 168,565 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-06-09 Option Award |
2025-06-11 4:24 pm |
N/A 2035-06-09 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
82,500 | $19.39 | 82,500 (Direct) |
View |
2025-01-21 Option Award |
2025-01-21 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
36,426 | $0 | 88,437 (Direct) |
View |
2024-01-16 Option Award |
2024-01-17 4:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
19,508 | $0 | 99,302 (Direct) |
View |
2024-01-16 Option Award |
2024-01-17 4:40 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
28,367 | $66.3 | 99,302 (Direct) |
View |
2023-09-18 Exercise |
2023-09-19 5:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
9,719 | $29.76 | 168,565 (Direct) |
View |
2023-09-18 Exercise |
2023-09-19 5:03 pm |
N/A 2030-08-16 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
9,719 | $0 | 168,565 (Direct) |
View |
2023-02-21 Option Award |
2023-02-22 06:45 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
23,909 | $0 | 77,526 (Direct) |
View |
2023-02-21 Tax Withholding |
2023-02-22 06:45 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
825 | $58.5 | 77,526 (Direct) |
View |
2023-01-27 Tax Withholding |
2023-01-30 5:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
551 | $52.77 | 54,442 (Direct) |
View |
2023-01-20 Tax Withholding |
2023-01-24 5:21 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
2,034 | $52.05 | 54,993 (Direct) |
View |
2022-04-25 Other |
2023-01-17 7:41 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
13,125 | $0 | 94,374 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:41 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
35,472 | $52.66 | 94,374 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:41 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
22,580 | $0 | 94,374 (Direct) |
View |
2022-01-28 Tax Withholding |
2022-02-01 6:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
650 | $38.59 | 35,555 (Direct) |
View |
2022-01-21 Option Award |
2022-01-25 4:51 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
63,002 | $0 | 73,156 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:38 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
65,625 | $0 | 65,625 (Direct) |
View |
Ownership |
2020-10-06 4:39 pm |
N/A 2030-08-16 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
0 | $0 | 125,000 (Direct) |
View |